Hyperuricemia induces endothelial dysfunction.
Level 5 - mechanism / opinion, no new human data
Animal and in vitro laboratory study without human participants
PubMed 15840020 · doi:10.1111/j.1523-1755.2005.00273.x
What was done
Male Sprague-Dawley rats were allocated to four experimental groups: vehicle control, allopurinol alone, oxonic acid (a uricase inhibitor given by gavage to induce hyperuricemia), or oxonic acid plus allopurinol. Rats were assessed at 1 and 7 days for serum uric acid, serum nitrites/nitrates (NOx), and systolic blood pressure. In parallel, the effect of soluble uric acid on basal and vascular endothelial growth factor (VEGF)-induced nitric oxide production was evaluated in cultured bovine aortic endothelial cells.
What was found
Oxonic acid induced mild hyperuricemia at 1 and 7 days (P < 0.05), which allopurinol reversed by day 7 (P < 0.001). Hyperuricemic rats exhibited significant reductions in serum NOx at both 1 and 7 days (P < 0.001); allopurinol slightly reversed this reduction at 1 day and fully reversed it at 7 days (P < 0.001). Serum uric acid correlated linearly with NOx concentrations (R2 = 0.56), and hyperuricemic rats showed a non-statistically significant trend toward elevated systolic blood pressure (P = NS). In vitro, uric acid directly inhibited both basal and VEGF-induced nitric oxide production in bovine aortic endothelial cells.
Why it matters
This study provides mechanistic evidence that elevated uric acid directly impairs endothelial nitric oxide generation, supporting a biological pathway linking hyperuricemia to endothelial dysfunction and vascular disease.
Limits
The study is restricted to a rat model and bovine cell culture, which may not translate directly to human cardiovascular physiology. Sample sizes (total n and per-group counts) were not reported in the abstract, and the 7-day study window was too short to establish sustained hemodynamic endpoints.
Cited by
- supports Uric acid directly impairs endothelial nitric oxide levels through arginine transport inhibition, enzyme inhibition, and direct scavenging or binding.
- supports Treating endothelial cells with uric acid blocks nitric oxide production.